Loading...
XHEL
OKDAV
Market cap209mUSD
Apr 04, Last price  
1.02EUR
Name

Oriola Oyj

Chart & Performance

D1W1MN
P/E
—
P/S
0.11
EPS
—
Div Yield, %
6.86%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
-0.49%
Revenues
1.68b
+12.44%
662,700,0001,377,300,0001,580,800,0001,713,100,0001,929,400,0002,146,000,0002,474,400,0002,598,500,0001,612,300,0001,626,300,0001,642,100,0001,527,700,0001,552,200,0001,721,300,0001,800,800,0001,882,400,0001,515,500,0001,493,800,0001,679,700,000
Net income
-20m
L-2.90%
9,600,00023,300,00027,500,00048,600,000102,100,000-24,100,00017,200,0005,800,000-212,300,00044,600,00042,800,00026,300,00012,700,0008,000,00011,300,00011,300,0004,800,000-20,700,000-20,100,000
CFO
39m
+303.13%
46,100,00039,000,000-18,100,000100,900,00088,700,00028,100,00046,100,00029,800,000-10,800,00085,600,00040,100,00023,700,000102,800,00084,400,00058,300,00040,000,00077,900,0009,600,00038,700,000
Dividend
Mar 20, 20240.07 EUR/sh
Earnings
Jul 16, 2025

Profile

Oriola Oyj provides healthcare and wellbeing products in Sweden, Finland, and internationally. The company offers over the counter (OTC) pharmaceutical and traded goods, vitamins, dietary supplements, cosmetics, skincare products, sports drinks, and wound care products. It also provides logistics, advisory, sales and marketing, and expert services for pharmaceutical companies, pharmacies, hospital pharmacies, veterinaries, as well as the grocery trade shops. In addition, the company offers pharmaceutical staffing and dose dispensing services for public and private healthcare operators, pharmacies, groceries, veterinarians, and retailers. As of December 31, 2021, it operated 319 pharmacies in Sweden, as well as operates online pharmacies. The company was formerly known as Oriola-KD Oyj and changed its name to Oriola Oyj in April 2017. Oriola Oyj is headquartered in Espoo, Finland.
URL
https://www.oriola.com/
IPO date
Jul 03, 2006
Employees
797
Domiciled in
FI
Incorporated in
FI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,679,700
12.44%
1,493,800
-1.43%
1,515,500
-19.49%
Cost of revenue
1,519,300
1,480,300
1,330,200
Unusual Expense (Income)
NOPBT
160,400
13,500
185,300
NOPBT Margin
9.55%
0.90%
12.23%
Operating Taxes
1,500
3,100
2,100
Tax Rate
0.94%
22.96%
1.13%
NOPAT
158,900
10,400
183,200
Net income
(20,100)
-2.90%
(20,700)
-531.25%
4,800
-57.52%
Dividends
(12,700)
(10,900)
(7,300)
Dividend yield
7.80%
5.32%
2.31%
Proceeds from repurchase of equity
(100)
(100)
(100)
BB yield
0.06%
0.05%
0.03%
Debt
Debt current
36,400
110,700
55,200
Long-term debt
52,100
16,000
84,300
Deferred revenue
1
Other long-term liabilities
14,100
14,300
12,400
Net debt
(25,000)
(260,700)
(295,700)
Cash flow
Cash from operating activities
38,700
9,600
77,900
CAPEX
(2,800)
(3,600)
(8,500)
Cash from investing activities
(2,800)
(3,500)
3,000
Cash from financing activities
(60,700)
(28,300)
(29,300)
FCF
206,500
85,400
162,100
Balance
Cash
113,500
138,400
160,600
Long term investments
249,000
274,600
Excess cash
29,515
312,710
359,425
Stockholders' equity
54,400
171,300
225,700
Invested Capital
194,085
132,100
130,600
ROIC
97.43%
7.92%
72.57%
ROCE
71.48%
4.41%
51.30%
EV
Common stock shares outstanding
181,423
181,423
181,423
Price
0.90
-20.53%
1.13
-35.06%
1.74
-12.34%
Market cap
162,918
-20.53%
205,007
-35.06%
315,675
-12.34%
EV
137,918
(55,693)
19,975
EBITDA
174,000
27,300
203,600
EV/EBITDA
0.79
0.10
Interest
9,200
2,200
Interest/NOPBT
68.15%
1.19%